Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001453687-20-000078

Options or other derivatives

  • Director acquired 20,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Sallin Aymeric · Director

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2020-06-19 Grant or award : show line 1 in the form Stock Option (Right to Buy) +20,000 $3.00 2030-06-18 20,000 20,000 D
Loading xslF345X03/wf-form4_159294523160862.xml…